Carson Leslie Foundation Invests in Medulloblastoma Prevention Research

The Carson Leslie Foundation (CLF), the only nonprofit specifically dedicated to funding medulloblastoma research, is pleased to announce a significant commitment made by CLF and other public and private funding sources to advance the prevention research of medulloblastoma, the most common cancerous brain tumor in children. Recruited to Texas with support from the Cancer Prevention and Research Institute of Texas (CPRIT) to continue his research, Dr. Michael Taylor, Director of the Neuro-Oncology Research Program at Texas Children’s Hospital, leads this research team.

Previous
Previous

Velorum Therapeutics Revolutionizes Cancer Treatment with Enhanced Efficacy

Next
Next

Johnson & Johnson Seeks FDA Approval for DARZALEX FASPRO® in Expanded Treatment Regimens